{"nct_id":"NCT00435396","title":"Study to Evaluate Safety and Immunogenicity of the GSK Bio CMV Vaccine in CMV-seronegative Healthy Male Adult Subjects","status":"COMPLETED","status_verified_date":"2017-05","start_date":"2007-02-22","start_date_type":"ACTUAL","primary_completion_date":"2008-08-27","primary_completion_date_type":"ACTUAL","completion_date":"2008-08-27","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}